All In Biotech

Drug Trial Radar · NCT04524273

Myasthenia Gravis Inebilizumab Trial

A Randomized, Double-blind, Multicenter, Placebo-controlled Phase 3 Study With Open-label Period to Evaluate the Efficacy and Safety of Inebilizumab in Adults With Myasthenia Gravis

Last checked: Nov 20, 2026Latest source record: May 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingPhase 3. Randomized with 238 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

238

Actual

Start

Oct 15, 2020

Primary completion

May 28, 2024

Study completion Jun 7, 2029

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Aug 24, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Randomized, double-blind, placebo-controlled, Phase 3, parallel-group study with optional open-label extension.

Conditions

  • Myasthenia Gravis

Interventions

  • inebilizumabDrug

    Participants will receive IV inebilizumab

  • IV PlaceboDrug

    Participants will receive IV placebo matched to inebilizumab

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline at Week 26 in Myasthenia Gravis Activities of Daily Living (MG-ADL) Score in the Overall Study PopulationTime frame: Baseline and Week 26

Locations

104 sites in 19 countries. Site status is shown where the registry gives one.

  • Viela Bio Investigative Site - 1015

    Orange, California

  • Viela Bio Investigative Site - 1002

    New Haven, Connecticut

  • Viela Bio Investigative Center - 1024

    Washington D.C., District of Columbia

  • Viela Bio Investigative Site - 1005

    Tampa, Florida

  • Viela Bio Investigative Site - 1012

    Kansas City, Kansas

  • Viela Bio Investigative Site - 1018

    Charlotte, North Carolina

  • Viela Bio Investigative Site - 1025

    Canton, Ohio

  • Viela Bio Investigative Site - 1001

    Cincinnati, Ohio

  • Viela Bio Investigative Site - 1009

    Columbus, Ohio

  • Viela Bio Investigative Site - 1008

    Pittsburgh, Pennsylvania

  • Viela Bio Investigative Site - 1019

    Austin, Texas

  • Viela Bio Investigative Site - 1003

    Houston, Texas

  • Viela Bio Investigative Site - 1014

    San Antonio, Texas

  • Viela Bio Investigative Site - 1017

    Salt Lake City, Utah

  • Viela Bio Investigative Site - 1004

    Burlington, Vermont

  • Viela Bio Investigative Site - 1006

    Richmond, Virginia

  • Viela Bio Investigative Site - 2001

    Buenos Aires, Argentina

  • VielaBio Investigative Site - 2002

    Buenos Aires, Argentina

  • Viela Bio Investigative Site - 2003

    Buenos Aires, Argentina

  • Viela Bio Investigative Site - 5203

    Grodno, Belarus

  • Viela Bio Investigative Site - 5204

    Minsk, Belarus

  • Viela Bio Investigative Site - 5201

    Vitebsk, Belarus

  • VielaBio Investigative Site - 2201

    Porto Alegre, Brazil

  • VielaBio Investigative Site - 2203

    Porto Alegre, Brazil

  • VielaBio Investigative Site - 2207

    Ribeirão Preto, Brazil

  • VielaBio Investigative Site - 2206

    São Paulo, Brazil

  • Viela Bio Investigative Site - 2205

    São Paulo, Brazil

  • Viela Bio Investigative Site - 1102

    Toronto, Ontario, Canada

  • Viela Bio Investigative Site - 1101

    Montreal, Quebec, Canada

  • Viela Bio Investigative Site - 1103

    Montreal, Quebec, Canada

  • Viela Bio Investigative Site 4009

    Beijing, China

  • Viela Bio Investigative Site - 4007

    Beijing, China

  • Viela Bio Investigative Site 4003

    Beijing, China

  • Viela Bio Investigative Site - 4005

    Guiyang, China

  • Viela Bio Investigative site 4010

    Hunan, China

  • Viela Bio Investigative Site - 4011

    Jinan, China

  • Viela Bio Investigative Site - 4006

    Shanghai, China

  • Viela Bio Investigative Site - 4008

    Suzhou, China

  • Viela Bio Investigative Site - 4004

    Tianjin, China

  • Viela Bio Investigative Site 4012

    Xi'an, China

Showing 40 of 104 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.